Diagnosis and management of multiple myeloma

This publication has 105 references indexed in Scilit:

• Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
  New England Journal of Medicine, 1999
• ALLOGENEIC BONE MARROW TRANSPLANTATION IN MULTIPLE MYELOMA
  British Journal of Haematology, 1996
• Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy
  New England Journal of Medicine, 1990
• Oral dosage of melphalan and response to treatment in multiple myeloma
  European Journal of Cancer and Clinical Oncology, 1990
• VAD‐based regimens as primary treatment for multiple myeloma
  American Journal of Hematology, 1990
• INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA
  The Lancet, 1989
• Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III —A randomized study from MGCS
  European Journal of Haematology, 1989
• Pharmacokinetics of oral melphalan in relation to renal function in multiple myeloma patients
  European Journal of Cancer and Clinical Oncology, 1989
• Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents
  New England Journal of Medicine, 1984
• Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma
  Metabolic Bone Disease and Related Research, 1982